α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 8, 2013, Pages 1748-1757

  Pérez Garay, Marta ^a   Arteta, Beatriz ^b   Llop, Esther ^a   Cobler, Lara ^d   Pagès, Lluís ^a   Ortiz, Rosa ^c   Ferri, María José ^c   De Bolós, Carme ^d   Figueras, Joan ^c   De Llorens, Rafael ^a   Vidal Vanaclocha, Fernando ^b,e   Peracaula, Rosa ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Metastasis; Migration; Pancreatic adenocarcinoma; 2,3 Sialyltransferases

Indexed keywords

ALPHA2,3 SIALYLTRANSFERASE ST3GAL III; ALPHA2,3 SIALYLTRANSFERASE ST3GAL IV; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 3; FUCOSYLTRANSFERASE 6; GLYCOSYLTRANSFERASE; SIALYL LEWIS X ANTIGEN; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; SURVIVAL RATE;

MUS MUSCULUS;

EID: 84879200371     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.05.015     Document Type: Article

References (68)

1. Aubert M, Panicot L, Crotte C, Gibier P, Lombardo D, Sadoulet MO, Mas E. Restora-tion of alpha(1, 2) fucosyltransferase activity decreases adhesive and metastaticproperties of human pancreatic cancer cells. Cancer Research 2000;60:1449-56.. (Pubitemid 30152020)
2. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nature Reviews Cancer 2002;2:897-909.. (Pubitemid 37328891)
3. Carvalho AS, Harduin-Lepers A, Magalhaes A, Machado E, Mendes N, Costa LT, Matthiesen R, Almeida R, Costa J, Reis CA. Differential expression of alpha-2, 3-sialyltransferases and alpha-1, 3/4-fucosyltransferases regulates the levelsof sialyl Lewis a and sialyl Lewisxin gastrointestinal carcinoma cells. Interna-tional Journal of Biochemistry and Cell Biology 2010;42:80-9..
4. Chang WW, Yu CY, Lin TW, Wang PH, Tsai YC. Soyasaponin I decreases the expressionof alpha2, 3-linked sialic acid on the cell surface and suppresses the metastaticpotential of B16F10 melanoma cells. Biochemical and Biophysical Research Communications 2006;341:614-9..
5. Chen JY, Tang YA, Huang SM, Juan HF, Wu LW, Sun YC, Wang SC, Wu KW, Bal-raj G, Chang TT, Li WS, Cheng HC, Wang YC. A novel sialyltransferase inhibitorsuppresses FAK/paxillin signaling and cancer angiogenesis and metastasis path-ways. Cancer Research 2011;71:473-83..
6. Chiang CH, Wang CH, Chang HC, More SV, Li WS, Hung WC. A novel sialyl-transferase inhibitor AL10 suppresses invasion and metastasis of lung cancercells by inhibiting integrin-mediated signaling. Journal of Cellular Physiology 2010;223:492-9..
7. Chiricolo M, Malagolini N, Bonfiglioli S, Dall'Olio F. Phenotypic changes induced byexpression of beta-galactoside alpha2, 6 sialyltransferase I in the human coloncancer cell line SW948. Glycobiology 2006;16:146-54.. (Pubitemid 43125970)
8. Christie DR, Shaikh FM, Lucas JA, Lucas t, 3rd JA, Bellis SL. ST6Gal-I expressionin ovarian cancer cells promotes an invasive phenotype by altering integringlycosylation and function. Journal of Ovarian Research 2008;1:3..
9. De Vries T, Palcic MP, Schoenmakers PS, Van Den Eijnden DH, Joziasse DH. Accep-tor specificity of GDP-Fuc:Gal beta 1 → 4GlcNAc-R alpha 3-fucosyltransferaseVI (FucT VI) expressed in insect cells as soluble, secreted enzyme. Glycobiology 1997;7:921-7..
10. de Vries T, Srnka CA, Palcic MM, Swiedler SJ, van den Eijnden DH, Macher BA. Acceptor specificity of different length constructs of human recombi-nant alpha 1, 3/4-fucosyltransferases. Replacement of the stem region and thetransmembrane domain of fucosyltransferase V by protein A results in anenzyme with GDP-fucose hydrolyzing activity. Journal of Biologcial Chemistry 1995;270:8712-22..
11. Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasisby concealing asialoglycoprotein receptor ligands. Proceedings of the National Academy of Sciences of the United States of America 2002;99:10042-7.. (Pubitemid 34831169)
12. Frazier ML, Fernandez E, de Llorens R, Brown NM, Pathak S, Cleary KR, Abbruzzese JL, Berry K, Olive M, Le Maistre A, Evans DB. Pancreatic adenocarcinoma cellline, MDAPanc-28, with features of both acinar and ductal cells. International Journal of Pancreatology 1996;19:31-8.. (Pubitemid 26078919)
13. Gomes J, Marcos NT, Berois N, Osinaga E, Magalhaes A, Pinto-de-Sousa J, Almeida R, Gartner F, Reis CA. Expression of UDP-N-acetyl-d-galactosamine: polypeptideN-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metapla-sia, and gastric carcinoma. Journal of Histochemistry and Cytochemistry 2009;57:79-86..
14. Gretschel S, Haensch W, Schlag PM, Kemmner W. Clinical relevance of sialyl-transferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology 2003;65:139-45.. (Pubitemid 37025975)
15. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie 2001;83:727-37.. (Pubitemid 32821237)
16. Higai K, Ishihara S, Matsumoto K. NFkappaB-p65 dependent transcriptional reg-ulation of glycosyltransferases in human colon adenocarcinoma HT-29 bystimulation with tumor necrosis factor alpha. Biological and Pharmaceutical Bulletin 2006;29:2372-7.. (Pubitemid 44885853)
17. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cellsurface. Nature Reviews Cancer 2004;4:45-60.. (Pubitemid 38082153)
18. Hosono J, Narita T, Kimura N, Sato M, Nakashio T, Kasai Y, Nonami T, Nakao A, TakagiH, Kannagi R. Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells. Journal of Surgical Oncology 1998;67:77-84.. (Pubitemid 28109971)
19. Hsu CC, Lin TW, Chang WW, Wu CY, Lo WH, Wang PH, Tsai YC. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecologic Oncology 2005;96:415-22..
20. Jin XL, Zheng SS, Wang BS, Chen HL. Correlation of glycosyltransferases mRNAexpression in extrahepatic bile duct carcinoma with clinical pathological char-acteristics. Hepatobiliary and Pancreatic Diseases International 2004;3:292-5..
21. Julien S, Videira PA, Delannoy P. Sialyl-Tn in cancer: (How) did we miss the target?Biomolecules 2012;2:435-66..
22. Kamisawa T, Isawa T, Koike M, Tsuruta K, Okamoto A. Hematogenous metastasesof pancreatic ductal carcinoma. Pancreas 1995;11:345-9..
23. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate- mediatedcell adhesion in cancer metastasis and angiogenesis. Cancer Science 2004;95:377-84.. (Pubitemid 38832679)
24. Kemmner W, Roefzaad C, Haensch W, Schlag PM. Glycosyltransferase expressionin human colonic tissue examined by oligonucleotide arrays. Biochimica et Bio-physica Acta 2003;1621:272-9.. (Pubitemid 36638580)
25. Kim GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ, Kim YS. Aberrant expressionof MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelialneoplasms of the pancreas. Gastroenterology 2002;123:1052-60..
26. Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glyco-proteins in cancer. Glycoconjugate Journal 1997;14:569-76.. (Pubitemid 27353200)
27. Kim YS, Itzkowitz SH, Yuan M, Chung Y, Satake K, Umeyama K, Hakomori S. Lex and Ley antigen expression in human pancreatic cancer. Cancer Research 1988;48:475-82.. (Pubitemid 18045790)
28. Kitagawa H, Paulson JC. Cloning of a novel alpha 2, 3-sialyltransferase that sia-lylates glycoprotein and glycolipid carbohydrate groups. Journal of Biological Chemistry 1994a;269:1394-401..
29. Kitagawa H, Paulson JC. Differential expression of five sialyltransferase genes inhuman tissues. Journal of Biological Chemistry 1994b;269:17872-8.. (Pubitemid 24206176)
30. Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, Tsuji S. Mouse beta-galactosidealpha 2, 3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 1997;7:469-79.. (Pubitemid 27246720)
31. Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, NishiharaS, Narimatsu H. Up-regulation of a set of glycosyltransferase genes in humancolorectal cancer. Laboratory Investigation 1998;78:797-811.. (Pubitemid 28347877)
32. Li Z, Yamada S, Inenaga S, Imamura T, Wu Y, Wang KY, Shimajiri S, Nakano R, Izumi H, Kohno K, Sasaguri Y. Polypeptide N-acetylgalactosaminyltransferase 6 expres-sion in pancreatic cancer is an independent prognostic factor indicating betteroverall survival. British Journal of Cancer 2011;104:1882-9..
33. Liu F, Qi HL, Zhang Y, Zhang XY, Chen HL. Transfection of the c-erbB2/neu geneupregulates the expression of sialyl LewisX, alpha1, 3-fucosyltransferase VII, and metastatic potential in a human hepatocarcinoma cell line. European Journal of Biochemistry 2001;268:3501-12.. (Pubitemid 32867312)
34. Liu F, Zhang Y, Zhang XY, Chen HL. Transfection of the nm23-H1 gene into humanhepatocarcinoma cell line inhibits the expression of sialyl LewisX, alpha1, 3 fuco-syltransferase VII, and metastatic potential. Journal of Cancer Research andClinical Oncology 2002;128:189-96.. (Pubitemid 34280376)
35. Lopez-Morales D, Velazquez-Marquez N, Valenzuela O, Santos-Lopez G, Reyes-LeyvaJ, Vallejo-Ruiz V. Enhanced sialyltransferases transcription in cervical intraep-ithelial neoplasia. Investigación clínica 2009;50:45-53..
36. Ma B, Simala-Grant JL, Taylor DE. Fucosylation in prokaryotes and eukaryotes. Gly-cobiology 2006;16:158r-84r. (Pubitemid 44811579)
37. Magnani JL. The discovery, biology, and drug development of sialyl Leaand sialylLex. Archives of Biochemistry and Biophysics 2004;426:122-31.. (Pubitemid 38684162)
38. Mao C, Domenico DR, Kim K, Hanson DJ, Howard JM. Observations on the develop-mental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. Archives of Surgery 1995;130:125-34..
39. Mas E, Pasqualini E, Caillol N, El Battari A, Crotte C, Lombardo D, Sadoulet MO. Fucosyltransferase activities in human pancreatic tissue: comparative studybetween cancer tissues and established tumoral cell lines. Glycobiology 1998;8:605-13.. (Pubitemid 28270582)
40. Mejias-Luque R, Lopez-Ferrer A, Garrido M, Fabra A, de Bolos C. Changes in theinvasive and metastatic capacities of HT-29/M3 cells induced by the expressionof fucosyltransferase 1. Cancer Science 2007;98:1000-5.. (Pubitemid 46865383)
41. Nakamori S, Nishihara S, Ikehara Y, Nagano H, Dono K, Sakon M, Narimatsu H, Monden M. Molecular mechanism involved in increased expression of sialylLewis antigens in ductal carcinoma of the pancreas. Journal of Experimentaland Clinical Cancer Research 1999;18:425-32..
42. Okajima T, Fukumoto S, Miyazaki H, Ishida H, Kiso M, Furukawa K, Urano T. Molec-ular cloning of a novel alpha2, 3-sialyltransferase (ST3Gal VI) that sialylates typeII lactosamine structures on glycoproteins and glycolipids. Journal of Biological Chemistry 1999;274:11479-86..
43. Onitsuka K, Shibao K, Nakayama Y, Minagawa N, Hirata K, Izumi H, Matsuo K, NagataN, Kitazato K, Kohno K, Itoh H. Prognostic significance of UDP-N-acetyl-alpha-d-galactosamine:polypeptide N- acetylgalactosaminyltransferase-3 (GalNAc-T3)expression in patients with gastric carcinoma. Cancer Science 2003;94:32-6.. (Pubitemid 36575855)
44. Padro M, Mejias-Luque R, Cobler L, Garrido M, Perez-Garay M, Puig S, PeracaulaR, de Bolos C. Regulation of glycosyltransferases and Lewis antigens expres-sion by IL-1beta and IL-6 in human gastric cancer cells. Glycoconjugate Journal 2011;28:99-110..
45. Peracaula R, Tabares G, Lopez-Ferrer A, Brossmer R, de Bolos C, de Llorens R. Roleof sialyltransferases involved in the biosynthesis of Lewis antigens in humanpancreatic tumour cells. Glycoconjugate Journal 2005;22:135-44.. (Pubitemid 41160332)
46. Perez-Garay M, Arteta B, Pages L, de Llorens R, de Bolos C, Vidal-Vanaclocha F, Pera-caula R. Alpha2, 3-sialyltransferase ST3Gal III modulates pancreatic cancer cellmotility and adhesion in vitro and enhances its metastatic potential in vivo. PLoSONE 2010:5..
47. Philipsen EK, Jorgensen M, Dabelsteen E. Expression of blood group-relatedcarbohydrate antigens in normal human pancreatic tissue. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1991;99:931-40..
48. Pinho S, Marcos NT, Ferreira B, Carvalho AS, Oliveira MJ, Santos-Silva F, Harduin-Lepers A, Reis CA. Biological significance of cancer-associated sialyl-Tn antigen:modulation of malignant phenotype in gastric carcinoma cells. Cancer Letters 2007;249:157-70.. (Pubitemid 46452924)
49. Real FX. A "catastrophic hypothesis" for pancreas cancer progression. Gastroen-terology 2003;124:1958-64.. (Pubitemid 36666791)
50. Recchi MA, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P. Multiplexreverse transcription polymerase chain reaction assessment of sialyltransferaseexpression in human breast cancer. Cancer Research 1998;58:4066-70.. (Pubitemid 28440556)
51. Sasaki K, Watanabe E, Kawashima K, Sekine S, Dohi T, Oshima M, Hanai N, NishiT, Hasegawa M. Expression cloning of a novel Gal beta (1-3/1-4) GlcNAcalpha 2, 3-sialyltransferase using lectin resistance selection. Journal of Biological Chemistry 1993;268:22782-7.. (Pubitemid 23318339)
52. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylationof beta1 integrins, observed in colon adenocarcinoma, may contribute to cancerprogression by up-regulating cell motility. Cancer Research 2005;65:4645-52.. (Pubitemid 40740800)
53. Shaikh FM, Seales EC, Clem WC, Hennessy KM, Zhuo Y, Bellis SL. Tumor cell migra-tion and invasion are regulated by expression of variant integrin glycoforms. Experimental Cell Research 2008;314:2941-50..
54. Shibao K, Izumi H, Nakayama Y, Ohta R, Nagata N, Nomoto M, Matsuo K, Yamada Y, Kitazato K, Itoh H, Kohno K. Expression of UDP-N-acetyl-alpha-d- galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 inrelation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 2002;94:1939-46.. (Pubitemid 34270046)
55. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: A Cancer Journal forClinicians 2012;62:10-29..
56. Sinn HP, Brown SA, Oberle E, Thompson JS. Analysis of the Lewisx epitope in humanpancreas and pancreatic adenocarcinomas. International Journal of Pancreatol-ogy 1992;11:125-35..
57. Souady J, Hulsewig M, Distler U, Haier J, Denz A, Pilarsky C, Senninger N, Dreisewerd K, Peter-Katalinic J, Muthing J. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. Glycobiology 2011;21:584-94..
58. Takahashi S, Oda T, Hasebe T, Sasaki S, Kinoshita T, Konishi M, Ueda T, NakahashiC, Ochiai T, Ochiai A. Overexpression of sialyl Lewisxantigen is associatedwith formation of extratumoral venous invasion and predicts postoperativedevelopment of massive hepatic metastasis in cases with pancreatic ductaladenocarcinoma. Pathobiology 2001;69:127-35.. (Pubitemid 34212083)
59. Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA. Overexpression of GalNAc-transferase GalNAc-T3 promotespancreatic cancer cell growth. Oncogene 2011;30:4843-54..
60. Trinchera M, Malagolini N, Chiricolo M, Santini D, Minni F, Caretti A, Dall'olio F. The biosynthesis of the selectin-ligand sialyl Lewisxin colorectal cancer tis-sues is regulated by fucosyltransferase VI and can be inhibited by an RNAinterference-based approach. International Journal of Biochemistry and Cell Biology 2011;43:130-9..
61. Ulloa F, Real FX. Differential distribution of sialic acid in alpha2, 3 and alpha2, 6linkages in the apical membrane of cultured epithelial cells and tissues. Journalof Histochemistry and Cytochemistry 2001;49:501-10..
62. Varki A. Essentials of glycobiology. Editor ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2009..
63. Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, Lai CR, Hsieh SL, Yuan CC. AlteredmRNA expressions of sialyltransferases in ovarian cancers. Gynecologic Oncol-ogy 2005;99:631-9..
64. Wang PH, Li YF, Juang CM, Lee YR, Chao HT, Ng HT, Tsai YC, Yuan CC. Expression ofsialyltransferase family members in cervix squamous cell carcinoma correlateswith lymph node metastasis. Gynecologic Oncology 2002;86:45-52.. (Pubitemid 34757050)
65. Weston BW, Nair RP, Larsen RD, Lowe JB. Isolation of a novel human alpha (1, 3)fuco-syltransferase gene and molecular comparison to the human Lewis blood groupalpha (1, 3/1, 4)fucosyltransferase gene. Syntenic, homologous, nonallelic genesencoding enzymes with distinct acceptor substrate specificities. Journal of Bio-logical Chemistry 1992a;267:4152-60..
66. Weston BW, Smith PL, Kelly RJ, Lowe JB. Molecular cloning of a fourth memberof a human alpha (1, 3)fucosyltransferase gene family. Multiple homologoussequences that determine expression of the Lewisx, sialyl Lewisx, and difucosylsialyl Lewisxepitopes. Journal of Biological Chemistry 1992b;267:24575-84..
67. Yamamoto H, Oviedo A, Sweeley C, Saito T, Moskal Jr. Alpha2, 6-sialylationof cell-surface N-glycans inhibits glioma formation in vivo. Cancer Research 2001;61:6822-9.. (Pubitemid 32896507)
68. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, VogelsteinB, Kinzler KW. Gene expression profiles in normal and cancer cells. Science 1997;276:1268-72.. (Pubitemid 27227367)